Investing.com - Hologic reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hologic announced earnings per share of $2.86 on revenue of $1.61B. Analysts polled by Investing.com anticipated EPS of $2.17 on revenue of $1.4B.
Hologic shares are down 0% from the beginning of the year and are trading at $72.47 , down-from-52-week-high.They are under-performing the Nasdaq which is up 2.97% from the start of the year.
Hologic follows other major Healthcare sector earnings this month
Hologic's report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.
Novartis ADR had missed expectations on Tuesday with fourth quarter EPS of $1.34 on revenue of $12.77B, compared to forecast for EPS of $1.36 on revenue of $12.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar